CMS Administrator Tavenner Emphasizes CMS And FDA Collaboration
This article was originally published in The Gray Sheet
Executive Summary
While speaking Sept. 24 at the 2013 AdvaMed conference, CMS Administrator Marilyn Tavenner outlined CMS’ priorities over the next three years, focusing on access, quality and cost with a specific emphasis on CMS collaborations with FDA.
You may also be interested in...
ACA Countdown: Details Emerging On Exchanges, Medicaid Expansion
Open enrollment in state exchange plans kicks off Oct. 1 and expanded Medicaid eligibility Jan. 1, and many states offer a preliminary view of how coverage will play out under the Affordable Care Act in 2014.
Medical Device Innovation Consortium Sets Priorities To Advance Reg Science
The heads of the newly formed private-public partnership comprising industry, academia and FDA describe the group’s top three projects to advance medical device regulatory science.
CDRH Launches ‘Innovation Pathway 2.0’ With End-Stage Renal Devices
Participants expect the program to tangibly reduce time to market and improve companies’ prospects for raising money.